Ferriprox for treatment of sickle cell anemia
FERRIPROX® (deferiprone) is an oral medication designed to chelate, or remove, iron overload from transfusions due to thalassemia syndromes when other chelation therapy, most commonly Exjade, does not work. The studies for approval were done for teh situation when teh initial chaltion did not work (second line) because Ferroprox may be inferior to Exjade in first line. This is not an innocuous drug; the most serious side effect seen in about
Read more